Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multi-variant Genetic Panel for Genetic Risk of Opioid Addiction.

Annals of clinical and laboratory science - 1 Aug 2017

Donaldson Keri, Demers Laurence, Taylor Kirk, Lopez Joe, Chang Sherman

Abstract excerpt

Over 116 million people worldwide have chronic pain and prescription dependence. In the US, opioids account for the majority of overdose deaths, and in 2014, almost 2 million Americans abused or were dependent on prescription opioids. Genetic factors may play a key role in opioid prescription addiction. Herein, we describe genetic variations between opioid addicted and non-addicted populations and derive a...

Topics

Join the communities discussing this publication.

Case-Control Studies
Cohort Studies
Follow-Up Studies
Genetic Markers
Heroin Dependence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Opioid-Related Disorders

Source

Identifiers

PMID: 28801372

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multi-variant Genetic Panel for Genetic Risk of Opioid Addiction.PMID 28801372Read ↗

High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial.Semantic proximity Read ↗

Genome-wide association analysis of opioid use disorder: A novel approach using clinical data.Semantic proximity Read ↗

Identification of a sex-stratified genetic algorithm for opioid addiction risk.Semantic proximity Read ↗

Candidate Genes from an FDA-Approved Algorithm Fail to Predict Opioid Use Disorder Risk in Over 450,000 VeteransSemantic proximity Read ↗

The genetics of the opioid system and specific drug addictions.Semantic proximity Read ↗

Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependence.Semantic proximity Read ↗

The phenomics and genetics of addictive and affective comorbidity in opioid use disorderSemantic proximity Read ↗

Genetic Variants Associated With Opioid Use DisorderSemantic proximity Read ↗

Genetic Vulnerability to Opioid Addiction.Semantic proximity Read ↗

Clinical Performance of a Gene-Based Machine Learning Classifier in Assessing Risk of Developing OUD in Subjects Taking Oral Opioids: A Prospective Observational Study.Semantic proximity Read ↗

Cost-utility analysis of single nucleotide polymorphism panel-based machine learning algorithm to predict risk of opioid use disorder.Semantic proximity Read ↗

A genome-wide Association study of the Count of Codeine prescriptions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.